Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERTEX PHARMACEUTICALS INC / MA Director's Dealing 2012

Apr 25, 2012

29864_dirs_2012-04-25_f5cfe837-9121-4e45-8d15-8adc90c8d55c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-12-31

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-25 Common Stock W 1946 $0.00 Acquired 733395 Direct

Footnotes

F1: The estate of a relative distributed these shares to Dr. Boger